Highlights from the 25th European Congress on Gynaecological Oncology in Barcelona: the ENYGO-IJGC Fellow Interviews

In March 2024, 12 European Network of Young Gynae Oncologists-International Journal of Gynaecological Cancer (ENYGO-IJGC) Editorial Fellows conducted 10 interviews with senior opinion leaders on original and controversial topics in the field of gynecologic oncology presented during the 25th European...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:International journal of gynecological cancer Ročník 34; číslo 10; s. 1522 - 1528
Hlavní autoři: Angeles, Martina Aida, Agusti, Nuria, Bonaldo, Giulio, Bizzarri, Nicolò, Bilir, Esra, Piedimonte, Sabrina, Olearo, Elena, Navarro Santana, Beatriz, Sahin Aker, Seda, El Hajj, Houssein, Ghirardi, Valentina, Kacperczyk-Bartnik, Joanna, Strojna, Aleksandra Natalia, Fotopoulou, Christina, Plante, Marie, Lorusso, Domenica, Cibula, David, Lindemann, Kristina, Scambia, Giovanni, McCormack, Mary, Leitao, Mario, Fagotti, Anna, Concin, Nicole, Martinez, Alejandra, Ramirez, Pedro T
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States BMJ Publishing Group Ltd 01.10.2024
Elsevier Inc
Elsevier Limited
Témata:
Accreditation
Biopsy
Cancer therapies
Cervical Cancer
Collaboration
Congresses as Topic
Developing countries
Disease
Endometrial cancer
Europe
Female
Genital cancers
Genital Neoplasms, Female
Genital Neoplasms, Female - therapy
Gynecologic Surgical Procedures
Gynecological cancer
Gynecology
Humans
Interviews as Topic
LDCs
Lymphatic system
Medical Oncology - methods
Meeting summary
Oncology
Ovarian Cancer
Radiation
Radiation therapy
Spain
Surgery
Tomography
Uterus
Europe
Spain
Ovarian Cancer
Genital Neoplasms, Female
Gynecologic Surgical Procedures
Cervical Cancer
Radiation
ISSN:1048-891X, 1525-1438, 1525-1438
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract In March 2024, 12 European Network of Young Gynae Oncologists-International Journal of Gynaecological Cancer (ENYGO-IJGC) Editorial Fellows conducted 10 interviews with senior opinion leaders on original and controversial topics in the field of gynecologic oncology presented during the 25th European Society of Gynaecological Oncology (ESGO) Congress in Barcelona, Spain. This article provides a summary and overview of the content of these discussions summarizing key points presented at the meeting. These selected interviews were chosen by consensus by the ENYGO-IJGC Editorial Fellows based on novelty and relevance to the field of gynecologic oncology.
AbstractList In March 2024, 12 European Network of Young Gynae Oncologists-International Journal of Gynaecological Cancer (ENYGO-IJGC) Editorial Fellows conducted 10 interviews with senior opinion leaders on original and controversial topics in the field of gynecologic oncology presented during the 25th European Society of Gynaecological Oncology (ESGO) Congress in Barcelona, Spain. This article provides a summary and overview of the content of these discussions summarizing key points presented at the meeting. These selected interviews were chosen by consensus by the ENYGO-IJGC Editorial Fellows based on novelty and relevance to the field of gynecologic oncology.
In March 2024, 12 European Network of Young Gynae Oncologists-International Journal of Gynaecological Cancer (ENYGO-IJGC) Editorial Fellows conducted 10 interviews with senior opinion leaders on original and controversial topics in the field of gynecologic oncology presented during the 25th European Society of Gynaecological Oncology (ESGO) Congress in Barcelona, Spain. This article provides a summary and overview of the content of these discussions summarizing key points presented at the meeting. These selected interviews were chosen by consensus by the ENYGO-IJGC Editorial Fellows based on novelty and relevance to the field of gynecologic oncology.In March 2024, 12 European Network of Young Gynae Oncologists-International Journal of Gynaecological Cancer (ENYGO-IJGC) Editorial Fellows conducted 10 interviews with senior opinion leaders on original and controversial topics in the field of gynecologic oncology presented during the 25th European Society of Gynaecological Oncology (ESGO) Congress in Barcelona, Spain. This article provides a summary and overview of the content of these discussions summarizing key points presented at the meeting. These selected interviews were chosen by consensus by the ENYGO-IJGC Editorial Fellows based on novelty and relevance to the field of gynecologic oncology.
In March 2024, 12 European Network of Young Gynae Oncologists- (ENYGO-IJGC) Editorial Fellows conducted 10 interviews with senior opinion leaders on original and controversial topics in the field of gynecologic oncology presented during the 25th European Society of Gynaecological Oncology (ESGO) Congress in Barcelona, Spain. This article provides a summary and overview of the content of these discussions summarizing key points presented at the meeting. These selected interviews were chosen by consensus by the ENYGO-IJGC Editorial Fellows based on novelty and relevance to the field of gynecologic oncology.
Author Angeles, Martina Aida
Scambia, Giovanni
Leitao, Mario
El Hajj, Houssein
Piedimonte, Sabrina
Olearo, Elena
Martinez, Alejandra
Fagotti, Anna
Kacperczyk-Bartnik, Joanna
Lindemann, Kristina
Agusti, Nuria
Ramirez, Pedro T
Bonaldo, Giulio
Cibula, David
Ghirardi, Valentina
Lorusso, Domenica
Bizzarri, Nicolò
Plante, Marie
Concin, Nicole
Bilir, Esra
Navarro Santana, Beatriz
McCormack, Mary
Strojna, Aleksandra Natalia
Sahin Aker, Seda
Fotopoulou, Christina
Author_xml – sequence: 1
  givenname: Martina Aida
  orcidid: 0000-0003-4401-3084
  surname: Angeles
  fullname: Angeles, Martina Aida
  email: martinangeles22@hotmail.com
  organization: Gynecologic Oncology Unit, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
– sequence: 2
  givenname: Nuria
  orcidid: 0000-0002-1165-0661
  surname: Agusti
  fullname: Agusti, Nuria
  organization: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
– sequence: 3
  givenname: Giulio
  orcidid: 0000-0002-9567-1629
  surname: Bonaldo
  fullname: Bonaldo, Giulio
  organization: Gynecologic Oncology Unit, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
– sequence: 4
  givenname: Nicolò
  orcidid: 0000-0002-1727-904X
  surname: Bizzarri
  fullname: Bizzarri, Nicolò
  organization: UOC Ginecologia Oncologica, Dipartimento di Scienza della Salute della Donna e del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
– sequence: 5
  givenname: Esra
  orcidid: 0000-0003-4499-6543
  surname: Bilir
  fullname: Bilir, Esra
  organization: Department of Gynecologic Oncology, Koc University School of Medicine, Istanbul, Turkey
– sequence: 6
  givenname: Sabrina
  surname: Piedimonte
  fullname: Piedimonte, Sabrina
  organization: Department of Obstetrics and Gynecology, University of Montreal, Montreal, Quebec, Canada
– sequence: 7
  givenname: Elena
  orcidid: 0000-0002-9936-5485
  surname: Olearo
  fullname: Olearo, Elena
  organization: Department of Obstetrics and Gynaecology, Azienda Ospdaliera Santa Croce e Carle Cuneo, Cuneo, Italy
– sequence: 8
  givenname: Beatriz
  orcidid: 0000-0002-5572-7843
  surname: Navarro Santana
  fullname: Navarro Santana, Beatriz
  organization: Insular University Hospital of Las Palmas, Las Palmas, Spain
– sequence: 9
  givenname: Seda
  orcidid: 0000-0001-6192-5726
  surname: Sahin Aker
  fullname: Sahin Aker, Seda
  organization: Department of Gynecologic Oncology, University of Health Sciences, Kayseri City Hospital, Kayseri, Turkey
– sequence: 10
  givenname: Houssein
  orcidid: 0000-0001-7613-8354
  surname: El Hajj
  fullname: El Hajj, Houssein
  organization: Surgery, Centre de Lutte Contre le Cancer Léon Bérard, Lyon, France
– sequence: 11
  givenname: Valentina
  orcidid: 0000-0002-0332-1200
  surname: Ghirardi
  fullname: Ghirardi, Valentina
  organization: UOC Ginecologia Oncologica, Dipartimento di Scienza della Salute della Donna e del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
– sequence: 12
  givenname: Joanna
  orcidid: 0000-0003-2539-3894
  surname: Kacperczyk-Bartnik
  fullname: Kacperczyk-Bartnik, Joanna
  organization: II Department of Obstetrics and Gynecology, Medical University of Warsaw, Warsaw, Poland
– sequence: 13
  givenname: Aleksandra Natalia
  orcidid: 0000-0002-8749-4642
  surname: Strojna
  fullname: Strojna, Aleksandra Natalia
  organization: Department of Gynecology and Gynecologic Oncology, Pomeranian Medical University in Szczecin, Essen, Germany
– sequence: 14
  givenname: Christina
  orcidid: 0000-0001-6375-9645
  surname: Fotopoulou
  fullname: Fotopoulou, Christina
  organization: Gynaecologic Oncology, Imperial College London Faculty of Medicine, London, UK
– sequence: 15
  givenname: Marie
  orcidid: 0000-0002-2298-7913
  surname: Plante
  fullname: Plante, Marie
  organization: Laval University, Quebec City, Quebec, Canada
– sequence: 16
  givenname: Domenica
  surname: Lorusso
  fullname: Lorusso, Domenica
  organization: Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
– sequence: 17
  givenname: David
  surname: Cibula
  fullname: Cibula, David
  organization: Department of Obstetrics and Gynecology, University of Prague, Prague, Czech Republic
– sequence: 18
  givenname: Kristina
  orcidid: 0000-0002-2162-0175
  surname: Lindemann
  fullname: Lindemann, Kristina
  organization: Department of Gynecological Oncology, Oslo University Hospital, Oslo, Norway
– sequence: 19
  givenname: Giovanni
  orcidid: 0000-0003-2758-1063
  surname: Scambia
  fullname: Scambia, Giovanni
  organization: UOC Ginecologia Oncologica, Dipartimento di Scienza della Salute della Donna e del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
– sequence: 20
  givenname: Mary
  surname: McCormack
  fullname: McCormack, Mary
  organization: Oncology, University College London Hospitals NHS Foundation Trust, London, UK
– sequence: 21
  givenname: Mario
  orcidid: 0000-0003-0818-3836
  surname: Leitao
  fullname: Leitao, Mario
  organization: Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, New York, USA
– sequence: 22
  givenname: Anna
  surname: Fagotti
  fullname: Fagotti, Anna
  organization: UOC Ginecologia Oncologica, Dipartimento di Scienza della Salute della Donna e del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
– sequence: 23
  givenname: Nicole
  orcidid: 0000-0002-9795-2643
  surname: Concin
  fullname: Concin, Nicole
  organization: Department of Gynecology and Obstetrics, Innsbruck Medical Univeristy, Innsbruck, Austria
– sequence: 24
  givenname: Alejandra
  orcidid: 0000-0002-7633-3536
  surname: Martinez
  fullname: Martinez, Alejandra
  organization: Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
– sequence: 25
  givenname: Pedro T
  orcidid: 0000-0002-6370-8052
  surname: Ramirez
  fullname: Ramirez, Pedro T
  organization: Department of Obstetrics and Gynecology, Houston Methodist Hospital, Neal Cancer Center, Houston, Texas, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39181697$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1vEzEQxS1URD_gzglZ4sKBBXu9jr29QZSmQRW5gAQny2vPJo527WDvUuW_r9NtQUKih9HM4fdGT--doxMfPCD0mpIPlLLZR7fbmKIkZVUQwgWpnqEzykte0IrJk3yTShaypj9O0XlKO0JIXZL6BTplNZV0VoszNFy7zbbLMyTcxtDjYQu45MMWL8YY9qA9nge_iZASDh4vD16DCV3YOKM7vPb39wE7jz_raKALXl_e_1h8_blcF6svyzm-gq4Lt3jlB4i_Hdyml-h5q7sErx72Bfp-tfg2vy5u1svV_NNN0bB6NhS6YdIwYk0pNLMCuLREy7JlNdOCMk5aUQO3UlaVtbyRpRQlNNI2orGioZxdoHfT330Mv0ZIg-pdyiY77SGMSTFSC8oJrWRG3_6D7sIYfXanGOWU53RzqE9ShJaCZSxTbx6osenBqn10vY4H9Zh6BsgEmBhSitD-QShRx2LVsVh1LFZNxWbJ5SSBnFcOMapkHHgD1kUwg7LBPSV-P4mbfvfX8X_xO4LjtOQ
Cites_doi 10.1136/ijgc-2024-005293
10.1002/ijgo.14923
10.1136/ijgc-2020-001973
10.1097/01.AOG.0000216004.22588.ce
10.1056/NEJMoa2308900
10.3322/caac.21763
10.1038/bjc.2013.230
10.1136/ijgc-2022-003701
10.1056/NEJMoa2302312
10.1136/ijgc-2022-003435
10.1200/JCO.2023.41.16_suppl.5550
10.1016/j.annonc.2022.05.009
10.1634/theoncologist.2019-0309
10.1136/ijgc-2022-004223
10.1016/j.ygyno.2024.06.015
10.1056/NEJMoa2103294
10.1097/PAS.0000000000001687
10.1136/ijgc-2020-002230
10.1002/14651858.CD001774.pub2
10.1136/ijgc-2023-004429
10.1056/NEJMoa2216334
10.1136/ijgc-2022-003543
10.1038/nature12113
10.1016/j.ajog.2019.04.035
10.1136/ijgc-2021-003053
10.1016/j.ejca.2021.02.009
10.1056/NEJMoa1806395
10.3322/caac.21660
ContentType Journal Article
Copyright IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.
2024 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.
2025 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.
Copyright_xml – notice: IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.
– notice: 2024 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.
– notice: 2025 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1136/ijgc-2024-005704
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest One Academic
ProQuest Central (New)
ProQuest Central (Alumni)
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList
ProQuest One Academic Middle East (New)
MEDLINE - Academic
ProQuest One Academic Middle East (New)

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1525-1438
EndPage 1528
ExternalDocumentID 39181697
10_1136_ijgc_2024_005704
S1048891X24035862
ijgc
Genre Journal Article
GeographicLocations Europe
Spain
GeographicLocations_xml – name: Spain
– name: Europe
GroupedDBID ---
.3N
.Z2
0R~
1OC
29J
31~
36B
4.4
53G
5GY
5VS
7X7
8-1
8FI
8FJ
AAHLL
AAKAS
AARTV
AAXUO
ABBUW
ABJNI
ABUWG
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFO
ACGFS
ACWDW
ACWRI
ACXNZ
ACXQS
ADZCM
AENEX
AFBPY
AFEBI
AFKRA
AFTRI
AFZJQ
AGINI
AHEFC
AIZYK
AJAOE
AJNYG
AJYBZ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BENPR
BFHJK
BQLVK
CAG
CCPQU
CO8
COF
CS3
CXRWF
DC6
DCZOG
E.X
EBS
EJD
EX3
F5P
FDB
FL-
FYUFA
FZ0
HAJ
HMCUK
HZI
HZ~
IHE
IN~
KD2
L-C
LH4
LW6
M41
O9-
OCUKA
OHYEH
ORVUJ
OUVQU
OVD
OXXIT
P2P
RMJ
ROL
S4S
TEORI
UDS
UKHRP
V2I
W3M
W99
WOW
X3V
X3W
YUY
AALRI
AAYWO
AAYXX
ACVFH
ADCNI
AEUPX
AFPUW
AIGII
AKBMS
AKYEP
AMRAJ
CITATION
PHGZM
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
K9.
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-b396t-ab38c30dc27a3d7e58d0a82f393a71350f79e5d8844dd5b82872eb8db7bd7b153
IEDL.DBID 7X7
ISICitedReferencesCount 0
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001298326000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1048-891X
1525-1438
IngestDate Tue Oct 14 01:16:42 EDT 2025
Tue Oct 07 07:39:01 EDT 2025
Tue Oct 07 07:42:17 EDT 2025
Mon Jul 21 06:04:14 EDT 2025
Thu Oct 09 00:33:29 EDT 2025
Sat Apr 19 15:58:10 EDT 2025
Thu Apr 24 22:49:54 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords Ovarian Cancer
Genital Neoplasms, Female
Gynecologic Surgical Procedures
Cervical Cancer
Radiation
Language English
License IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b396t-ab38c30dc27a3d7e58d0a82f393a71350f79e5d8844dd5b82872eb8db7bd7b153
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Interview-3
ORCID 0000-0003-0818-3836
0000-0002-9795-2643
0000-0003-4499-6543
0000-0001-6192-5726
0000-0001-6375-9645
0000-0002-9567-1629
0000-0002-7633-3536
0000-0002-5572-7843
0000-0003-2758-1063
0000-0002-8749-4642
0000-0002-9936-5485
0000-0002-6370-8052
0000-0003-4401-3084
0000-0002-2298-7913
0000-0002-2162-0175
0000-0002-1727-904X
0000-0001-7613-8354
0000-0003-2539-3894
0000-0002-1165-0661
0000-0002-0332-1200
PMID 39181697
PQID 3101273701
PQPubID 5161120
PageCount 7
ParticipantIDs proquest_miscellaneous_3097150148
proquest_journals_3151557014
proquest_journals_3101273701
pubmed_primary_39181697
crossref_primary_10_1136_ijgc_2024_005704
elsevier_sciencedirect_doi_10_1136_ijgc_2024_005704
bmj_journals_10_1136_ijgc_2024_005704
PublicationCentury 2000
PublicationDate 2024-10-01
PublicationDateYYYYMMDD 2024-10-01
PublicationDate_xml – month: 10
  year: 2024
  text: 2024-10-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Kidlington
PublicationTitle International journal of gynecological cancer
PublicationTitleAbbrev Int J Gynecol Cancer
PublicationTitleAlternate Int J Gynecol Cancer
PublicationYear 2024
Publisher BMJ Publishing Group Ltd
Elsevier Inc
Elsevier Limited
Publisher_xml – name: BMJ Publishing Group Ltd
– name: Elsevier Inc
– name: Elsevier Limited
References Cibula, Raspollini, Planchamp (R25) 2023; 33
Macchia, Lazzari, Colombo (R17) 2020; 25
(R24) 2004; 2015
Berek, Matias-Guiu, Creutzberg (R5) 2023; 162
Oaknin, Bosse, Creutzberg (R27) 2022; 33
Plante, Kwon, Ferguson (R4) 2024; 390
Warnnissorn, Watkins, Young (R20) 2021; 45
Kocian, Kohler, Bajsova (R10) 2024; 188
Mirza, Chase, Slomovitz (R8) 2023; 388
Harter, Mouret-Reynier, Lorusso (R19) 2023; 41
Sung, Ferlay, Siegel (R23) 2021; 71
Hollis, Carmichael, Meynert (R15) 2019; 221
Mathevet, Lécuru, Uzan (R12) 2021; 148
Harter, Sehouli, Vergote (R16) 2021; 385
Martinez, Lecuru, Bizzarri (R2) 2023; 33
Schettino, Musacchio, Bartoletti (R18) 2022; 32
McCormack, Kadalayil, Hackshaw (R26) 2013; 108
Chelariu-Raicu, Mahner, Moore (R9) 2023; 33
Kandoth, Schultz (R6) 2013; 497
Concin, Matias-Guiu, Vergote (R7) 2021; 31
Smith, Berwick, Verschraegen (R21) 2006; 107
Siegel, Miller, Wagle (R22) 2023; 73
Cerda, Lu, Scott (R14) 2022; 32
Marnitz, Tsunoda, Martus (R3) 2020; 30
Eskander, Sill, Beffa (R28) 2023; 388
Fotopoulou, Eriksson, Planchamp (R1) 2024; 34
Ramirez, Frumovitz, Pareja (R11) 2018; 379
Palluzzi, Marchetti, Cappuccio (R13) 2022
Chelariu-Raicu, Mahner, Moore (bb0050) 2023; 33
Neoadjuvant Chemotherapy for Cervical Cancer Meta-analysis Collaboration (NACCCMA) Collaboration (bb0125) 2004; 2015
Kocian, Kohler, Bajsova (bb0055) 2024; 188
Harter, Mouret-Reynier, Lorusso (bb0100) 2023; 41
Oaknin, Bosse, Creutzberg (bb0140) 2022; 33
Harter, Sehouli, Vergote (bb0085) 2021; 385
Sung, Ferlay, Siegel (bb0120) 2021; 71
Ramirez, Frumovitz, Pareja (bb0060) 2018; 379
Macchia, Lazzari, Colombo (bb0090) 2020; 25
Eskander, Sill, Beffa (bb0145) 2023; 388
Plante, Kwon, Ferguson (bb0025) 2024; 390
Cancer Genome Atlas Research Network (bb0035) 2013; 497
Smith, Berwick, Verschraegen (bb0110) 2006; 107
Berek, Matias-Guiu, Creutzberg (bb0030) 2023; 162
Concin, Matias-Guiu, Vergote (bb0040) 2021; 31
Schettino, Musacchio, Bartoletti (bb0095) 2022; 32
Palluzzi, Marchetti, Cappuccio (bb0070) 2022
Cibula, Raspollini, Planchamp (bb0130) 2023; 33
Martinez, Lecuru, Bizzarri (bb0015) 2023; 33
Fotopoulou, Eriksson, Planchamp (bb0010) 2024; 34
Mirza, Chase, Slomovitz (bb0045) 2023; 388
McCormack, Kadalayil, Hackshaw (bb0135) 2013; 108
Hollis, Carmichael, Meynert (bb0080) 2019; 221
Mathevet, Lécuru, Uzan (bb0065) 2021; 148
Siegel, Miller, Wagle (bb0115) 2023; 73
Cerda, Lu, Scott (bb0075) 2022; 32
Warnnissorn, Watkins, Young (bb0105) 2021; 45
Marnitz, Tsunoda, Martus (bb0020) 2020; 30
Plante (10.1136/ijgc-2024-005704_bb0025) 2024; 390
Mirza (10.1136/ijgc-2024-005704_bb0045) 2023; 388
Eskander (10.1136/ijgc-2024-005704_bb0145) 2023; 388
Ramirez (10.1136/ijgc-2024-005704_bb0060) 2018; 379
Kocian (10.1136/ijgc-2024-005704_bb0055) 2024; 188
Cerda (10.1136/ijgc-2024-005704_bb0075) 2022; 32
Hollis (10.1136/ijgc-2024-005704_bb0080) 2019; 221
Schettino (10.1136/ijgc-2024-005704_bb0095) 2022; 32
Marnitz (10.1136/ijgc-2024-005704_bb0020) 2020; 30
Warnnissorn (10.1136/ijgc-2024-005704_bb0105) 2021; 45
Palluzzi (10.1136/ijgc-2024-005704_bb0070) 2022
Mathevet (10.1136/ijgc-2024-005704_bb0065) 2021; 148
Chelariu-Raicu (10.1136/ijgc-2024-005704_bb0050) 2023; 33
Macchia (10.1136/ijgc-2024-005704_bb0090) 2020; 25
Sung (10.1136/ijgc-2024-005704_bb0120) 2021; 71
Martinez (10.1136/ijgc-2024-005704_bb0015) 2023; 33
McCormack (10.1136/ijgc-2024-005704_bb0135) 2013; 108
Fotopoulou (10.1136/ijgc-2024-005704_bb0010) 2024; 34
Neoadjuvant Chemotherapy for Cervical Cancer Meta-analysis Collaboration (NACCCMA) Collaboration (10.1136/ijgc-2024-005704_bb0125) 2004; 2015
Cancer Genome Atlas Research Network (10.1136/ijgc-2024-005704_bb0035) 2013; 497
Harter (10.1136/ijgc-2024-005704_bb0085) 2021; 385
Oaknin (10.1136/ijgc-2024-005704_bb0140) 2022; 33
Berek (10.1136/ijgc-2024-005704_bb0030) 2023; 162
Smith (10.1136/ijgc-2024-005704_bb0110) 2006; 107
Cibula (10.1136/ijgc-2024-005704_bb0130) 2023; 33
Harter (10.1136/ijgc-2024-005704_bb0100) 2023; 41
Concin (10.1136/ijgc-2024-005704_bb0040) 2021; 31
Siegel (10.1136/ijgc-2024-005704_bb0115) 2023; 73
References_xml – volume: 34
  start-page: 480
  year: 2024
  ident: R1
  article-title: European society of gynaecological oncology expanded quality indicators and accreditation for cervical cancer management
  publication-title: Int J Gynecol Cancer
  doi: 10.1136/ijgc-2024-005293
– volume: 162
  start-page: 383
  year: 2023
  ident: R5
  article-title: FIGO staging of endometrial cancer: 2023
  publication-title: Int J Gynecol Obstet
  doi: 10.1002/ijgo.14923
– volume: 30
  start-page: 1855
  year: 2020
  ident: R3
  article-title: Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study
  publication-title: Int J Gynecol Cancer
  doi: 10.1136/ijgc-2020-001973
– volume: 107
  start-page: 1075
  year: 2006
  ident: R21
  article-title: Incidence and survival rates for female malignant germ cell tumors
  publication-title: Obstet Gynecol
  doi: 10.1097/01.AOG.0000216004.22588.ce
– volume: 390
  start-page: 819
  year: 2024
  ident: R4
  article-title: Simple versus radical hysterectomy in women with low-risk cervical cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2308900
– volume: 73
  start-page: 17
  year: 2023
  ident: R22
  article-title: Cancer statistics, 2023
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21763
– volume: 108
  start-page: 2464
  year: 2013
  ident: R26
  article-title: A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer
  publication-title: Br J Cancer
  doi: 10.1038/bjc.2013.230
– volume: 33
  start-page: 420
  year: 2023
  ident: R9
  article-title: Integrating antibody drug conjugates in the management of gynecologic cancers
  publication-title: Int J Gynecol Cancer
  doi: 10.1136/ijgc-2022-003701
– volume: 388
  start-page: 2159
  year: 2023
  ident: R28
  article-title: Pembrolizumab plus chemotherapy in advanced endometrial cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2302312
– volume: 32
  start-page: 799
  year: 2022
  ident: R18
  article-title: Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer: phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groups
  publication-title: Int J Gynecol Cancer
  doi: 10.1136/ijgc-2022-003435
– volume: 41
  start-page: 5550
  year: 2023
  ident: R19
  article-title: Efficacy of subsequent therapies in patients (pts) with advanced ovarian cancer (AOC) in the phase III PAOLA-1/ENGOT-ov25 trial according to whether disease progression occurred during or after the end of olaparib (ola) maintenance
  publication-title: Am Soc Clin Oncol Poster Sess
  doi: 10.1200/JCO.2023.41.16_suppl.5550
– volume: 33
  start-page: 860
  year: 2022
  ident: R27
  article-title: Endometrial cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up
  publication-title: Ann Oncol
  doi: 10.1016/j.annonc.2022.05.009
– volume: 25
  start-page: e311
  year: 2020
  ident: R17
  article-title: A large, multicenter, retrospective study on efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (MITO RT1 Study): a collaboration of MITO, AIRO GYN, and MaNGO groups
  publication-title: Oncologist
  doi: 10.1634/theoncologist.2019-0309
– volume: 33
  start-page: 293
  year: 2023
  ident: R2
  article-title: PARa-aOrtic lymphadenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study
  publication-title: Int J Gynecol Cancer
  doi: 10.1136/ijgc-2022-004223
– volume: 188
  start-page: 83
  year: 2024
  ident: R10
  article-title: Sentinel lymph node pathological ultrastaging: final outcome of the sentix prospective international study in patients with early-stage cervical cancer
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2024.06.015
– volume: 385
  start-page: 2123
  year: 2021
  ident: R16
  article-title: Randomized trial of cytoreductive surgery for relapsed ovarian cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2103294
– volume: 45
  start-page: 1009
  year: 2021
  ident: R20
  article-title: Dysgerminoma of the ovary: an analysis of 140 cases emphasizing unusual microscopic findings and resultant diagnostic problems
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0000000000001687
– volume: 31
  start-page: 12
  year: 2021
  ident: R7
  article-title: ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
  publication-title: Int J Gynecol Cancer
  doi: 10.1136/ijgc-2020-002230
– volume: 2015
  year: 2004
  ident: R24
  article-title: Neoadjuvant chemotherapy for locally advanced cervix cancer
  publication-title: Cochrane Database Syst Rev
  doi: 10.1002/14651858.CD001774.pub2
– volume: 33
  start-page: 649
  year: 2023
  ident: R25
  article-title: ESGO/ESTRO/ESP guidelines for the management of patients with cervical cancer - Update 2023
  publication-title: Int J Gynecol Cancer
  doi: 10.1136/ijgc-2023-004429
– volume: 388
  start-page: 2145
  year: 2023
  ident: R8
  article-title: Dostarlimab for primary advanced or recurrent endometrial cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2216334
– start-page: 1164
  year: 2022
  ident: R13
  article-title: Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance
  publication-title: Int J Gynecol Cancer
  doi: 10.1136/ijgc-2022-003543
– volume: 497
  start-page: 67
  year: 2013
  ident: R6
  article-title: Integrated genomic characterization of endometrial carcinoma
  publication-title: Nat New Biol
  doi: 10.1038/nature12113
– volume: 221
  start-page: 245
  year: 2019
  ident: R15
  article-title: Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/j.ajog.2019.04.035
– volume: 32
  start-page: 153
  year: 2022
  ident: R14
  article-title: Evaluation of patterns of progression on poly (ADP-ribose) polymerase inhibitor (PARPi) maintenance in ovarian cancer: a cross-sectional study
  publication-title: Int J Gynecol Cancer
  doi: 10.1136/ijgc-2021-003053
– volume: 148
  start-page: 307
  year: 2021
  ident: R12
  article-title: Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: results of a multicentre randomised trial (SENTICOL-2)
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2021.02.009
– volume: 379
  start-page: 1895
  year: 2018
  ident: R11
  article-title: Minimally invasive versus abdominal radical hysterectomy for cervical cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1806395
– volume: 71
  start-page: 209
  year: 2021
  ident: R23
  article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21660
– volume: 388
  start-page: 2159
  year: 2023
  end-page: 70
  ident: bb0145
  article-title: Pembrolizumab plus chemotherapy in advanced endometrial cancer
  publication-title: N Engl J Med
– volume: 71
  start-page: 209
  year: 2021
  end-page: 49
  ident: bb0120
  article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA Cancer J Clin
– volume: 2015
  year: 2004
  ident: bb0125
  article-title: Neoadjuvant chemotherapy for locally advanced cervix cancer
  publication-title: Cochrane Database Syst Rev
– volume: 148
  start-page: 307
  year: 2021
  end-page: 15
  ident: bb0065
  article-title: Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: results of a multicentre randomised trial (SENTICOL-2)
  publication-title: Eur J Cancer
– volume: 107
  start-page: 1075
  year: 2006
  end-page: 85
  ident: bb0110
  article-title: Incidence and survival rates for female malignant germ cell tumors
  publication-title: Obstet Gynecol
– volume: 33
  start-page: 293
  year: 2023
  end-page: 8
  ident: bb0015
  article-title: PARa-aOrtic lymphadenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study
  publication-title: Int J Gynecol Cancer
– start-page: 1164
  year: 2022
  end-page: 70
  ident: bb0070
  article-title: Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance
  publication-title: Int J Gynecol Cancer
– volume: 32
  start-page: 153
  year: 2022
  end-page: 8
  ident: bb0075
  article-title: Evaluation of patterns of progression on poly (ADP-ribose) polymerase inhibitor (PARPi) maintenance in ovarian cancer: a cross-sectional study
  publication-title: Int J Gynecol Cancer
– volume: 25
  start-page: e311
  year: 2020
  end-page: 20
  ident: bb0090
  article-title: A large, multicenter, retrospective study on efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (MITO RT1 Study): a collaboration of MITO, AIRO GYN, and MaNGO groups
  publication-title: Oncologist
– volume: 34
  start-page: 480
  year: 2024
  end-page: 9
  ident: bb0010
  article-title: European society of gynaecological oncology expanded quality indicators and accreditation for cervical cancer management
  publication-title: Int J Gynecol Cancer
– volume: 388
  start-page: 2145
  year: 2023
  end-page: 58
  ident: bb0045
  article-title: Dostarlimab for primary advanced or recurrent endometrial cancer
  publication-title: N Engl J Med
– volume: 162
  start-page: 383
  year: 2023
  end-page: 94
  ident: bb0030
  article-title: FIGO staging of endometrial cancer: 2023
  publication-title: Int J Gynecol Obstet
– volume: 497
  start-page: 67
  year: 2013
  end-page: 73
  ident: bb0035
  article-title: Integrated genomic characterization of endometrial carcinoma
  publication-title: Nat New Biol
– volume: 390
  start-page: 819
  year: 2024
  end-page: 29
  ident: bb0025
  article-title: Simple versus radical hysterectomy in women with low-risk cervical cancer
  publication-title: N Engl J Med
– volume: 221
  start-page: 245
  year: 2019
  ident: bb0080
  article-title: Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse
  publication-title: Am J Obstet Gynecol
– volume: 30
  start-page: 1855
  year: 2020
  end-page: 61
  ident: bb0020
  article-title: Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study
  publication-title: Int J Gynecol Cancer
– volume: 41
  start-page: 5550
  year: 2023
  ident: bb0100
  article-title: Efficacy of subsequent therapies in patients (pts) with advanced ovarian cancer (AOC) in the phase III PAOLA-1/ENGOT-ov25 trial according to whether disease progression occurred during or after the end of olaparib (ola) maintenance
  publication-title: Am Soc Clin Oncol Poster Sess
– volume: 33
  start-page: 860
  year: 2022
  end-page: 77
  ident: bb0140
  article-title: Endometrial cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up
  publication-title: Ann Oncol
– volume: 379
  start-page: 1895
  year: 2018
  end-page: 904
  ident: bb0060
  article-title: Minimally invasive versus abdominal radical hysterectomy for cervical cancer
  publication-title: N Engl J Med
– volume: 45
  start-page: 1009
  year: 2021
  end-page: 27
  ident: bb0105
  article-title: Dysgerminoma of the ovary: an analysis of 140 cases emphasizing unusual microscopic findings and resultant diagnostic problems
  publication-title: Am J Surg Pathol
– volume: 33
  start-page: 649
  year: 2023
  end-page: 66
  ident: bb0130
  article-title: ESGO/ESTRO/ESP guidelines for the management of patients with cervical cancer - Update 2023
  publication-title: Int J Gynecol Cancer
– volume: 73
  start-page: 17
  year: 2023
  end-page: 48
  ident: bb0115
  article-title: Cancer statistics, 2023
  publication-title: CA Cancer J Clin
– volume: 188
  start-page: 83
  year: 2024
  end-page: 9
  ident: bb0055
  article-title: Sentinel lymph node pathological ultrastaging: final outcome of the sentix prospective international study in patients with early-stage cervical cancer
  publication-title: Gynecol Oncol
– volume: 108
  start-page: 2464
  year: 2013
  end-page: 9
  ident: bb0135
  article-title: A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer
  publication-title: Br J Cancer
– volume: 33
  start-page: 420
  year: 2023
  end-page: 9
  ident: bb0050
  article-title: Integrating antibody drug conjugates in the management of gynecologic cancers
  publication-title: Int J Gynecol Cancer
– volume: 385
  start-page: 2123
  year: 2021
  end-page: 31
  ident: bb0085
  article-title: Randomized trial of cytoreductive surgery for relapsed ovarian cancer
  publication-title: N Engl J Med
– volume: 31
  start-page: 12
  year: 2021
  end-page: 39
  ident: bb0040
  article-title: ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
  publication-title: Int J Gynecol Cancer
– volume: 32
  start-page: 799
  year: 2022
  end-page: 803
  ident: bb0095
  article-title: Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer: phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groups
  publication-title: Int J Gynecol Cancer
– volume: 34
  start-page: 480
  year: 2024
  ident: 10.1136/ijgc-2024-005704_bb0010
  article-title: European society of gynaecological oncology expanded quality indicators and accreditation for cervical cancer management
  publication-title: Int J Gynecol Cancer
  doi: 10.1136/ijgc-2024-005293
– volume: 108
  start-page: 2464
  year: 2013
  ident: 10.1136/ijgc-2024-005704_bb0135
  article-title: A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer
  publication-title: Br J Cancer
  doi: 10.1038/bjc.2013.230
– start-page: 1164
  year: 2022
  ident: 10.1136/ijgc-2024-005704_bb0070
  article-title: Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance
  publication-title: Int J Gynecol Cancer
  doi: 10.1136/ijgc-2022-003543
– volume: 33
  start-page: 860
  year: 2022
  ident: 10.1136/ijgc-2024-005704_bb0140
  article-title: Endometrial cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up
  publication-title: Ann Oncol
  doi: 10.1016/j.annonc.2022.05.009
– volume: 45
  start-page: 1009
  year: 2021
  ident: 10.1136/ijgc-2024-005704_bb0105
  article-title: Dysgerminoma of the ovary: an analysis of 140 cases emphasizing unusual microscopic findings and resultant diagnostic problems
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0000000000001687
– volume: 32
  start-page: 153
  year: 2022
  ident: 10.1136/ijgc-2024-005704_bb0075
  article-title: Evaluation of patterns of progression on poly (ADP-ribose) polymerase inhibitor (PARPi) maintenance in ovarian cancer: a cross-sectional study
  publication-title: Int J Gynecol Cancer
  doi: 10.1136/ijgc-2021-003053
– volume: 388
  start-page: 2159
  year: 2023
  ident: 10.1136/ijgc-2024-005704_bb0145
  article-title: Pembrolizumab plus chemotherapy in advanced endometrial cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2302312
– volume: 497
  start-page: 67
  year: 2013
  ident: 10.1136/ijgc-2024-005704_bb0035
  article-title: Integrated genomic characterization of endometrial carcinoma
  publication-title: Nat New Biol
  doi: 10.1038/nature12113
– volume: 33
  start-page: 420
  year: 2023
  ident: 10.1136/ijgc-2024-005704_bb0050
  article-title: Integrating antibody drug conjugates in the management of gynecologic cancers
  publication-title: Int J Gynecol Cancer
  doi: 10.1136/ijgc-2022-003701
– volume: 71
  start-page: 209
  year: 2021
  ident: 10.1136/ijgc-2024-005704_bb0120
  article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA Cancer J Clin
– volume: 221
  start-page: 245
  year: 2019
  ident: 10.1136/ijgc-2024-005704_bb0080
  article-title: Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/j.ajog.2019.04.035
– volume: 148
  start-page: 307
  year: 2021
  ident: 10.1136/ijgc-2024-005704_bb0065
  article-title: Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: results of a multicentre randomised trial (SENTICOL-2)
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2021.02.009
– volume: 30
  start-page: 1855
  year: 2020
  ident: 10.1136/ijgc-2024-005704_bb0020
  article-title: Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study
  publication-title: Int J Gynecol Cancer
  doi: 10.1136/ijgc-2020-001973
– volume: 32
  start-page: 799
  year: 2022
  ident: 10.1136/ijgc-2024-005704_bb0095
  article-title: Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer: phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groups
  publication-title: Int J Gynecol Cancer
  doi: 10.1136/ijgc-2022-003435
– volume: 73
  start-page: 17
  year: 2023
  ident: 10.1136/ijgc-2024-005704_bb0115
  article-title: Cancer statistics, 2023
  publication-title: CA Cancer J Clin
– volume: 41
  start-page: 5550
  year: 2023
  ident: 10.1136/ijgc-2024-005704_bb0100
  article-title: Efficacy of subsequent therapies in patients (pts) with advanced ovarian cancer (AOC) in the phase III PAOLA-1/ENGOT-ov25 trial according to whether disease progression occurred during or after the end of olaparib (ola) maintenance
  publication-title: Am Soc Clin Oncol Poster Sess
  doi: 10.1200/JCO.2023.41.16_suppl.5550
– volume: 31
  start-page: 12
  year: 2021
  ident: 10.1136/ijgc-2024-005704_bb0040
  article-title: ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
  publication-title: Int J Gynecol Cancer
  doi: 10.1136/ijgc-2020-002230
– volume: 25
  start-page: e311
  year: 2020
  ident: 10.1136/ijgc-2024-005704_bb0090
  article-title: A large, multicenter, retrospective study on efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (MITO RT1 Study): a collaboration of MITO, AIRO GYN, and MaNGO groups
  publication-title: Oncologist
  doi: 10.1634/theoncologist.2019-0309
– volume: 2015
  year: 2004
  ident: 10.1136/ijgc-2024-005704_bb0125
  article-title: Neoadjuvant chemotherapy for locally advanced cervix cancer
  publication-title: Cochrane Database Syst Rev
– volume: 390
  start-page: 819
  year: 2024
  ident: 10.1136/ijgc-2024-005704_bb0025
  article-title: Simple versus radical hysterectomy in women with low-risk cervical cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2308900
– volume: 162
  start-page: 383
  year: 2023
  ident: 10.1136/ijgc-2024-005704_bb0030
  article-title: FIGO staging of endometrial cancer: 2023
  publication-title: Int J Gynecol Obstet
  doi: 10.1002/ijgo.14923
– volume: 107
  start-page: 1075
  year: 2006
  ident: 10.1136/ijgc-2024-005704_bb0110
  article-title: Incidence and survival rates for female malignant germ cell tumors
  publication-title: Obstet Gynecol
  doi: 10.1097/01.AOG.0000216004.22588.ce
– volume: 385
  start-page: 2123
  year: 2021
  ident: 10.1136/ijgc-2024-005704_bb0085
  article-title: Randomized trial of cytoreductive surgery for relapsed ovarian cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2103294
– volume: 33
  start-page: 293
  year: 2023
  ident: 10.1136/ijgc-2024-005704_bb0015
  article-title: PARa-aOrtic lymphadenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study
  publication-title: Int J Gynecol Cancer
  doi: 10.1136/ijgc-2022-004223
– volume: 388
  start-page: 2145
  year: 2023
  ident: 10.1136/ijgc-2024-005704_bb0045
  article-title: Dostarlimab for primary advanced or recurrent endometrial cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2216334
– volume: 188
  start-page: 83
  year: 2024
  ident: 10.1136/ijgc-2024-005704_bb0055
  article-title: Sentinel lymph node pathological ultrastaging: final outcome of the sentix prospective international study in patients with early-stage cervical cancer
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2024.06.015
– volume: 379
  start-page: 1895
  year: 2018
  ident: 10.1136/ijgc-2024-005704_bb0060
  article-title: Minimally invasive versus abdominal radical hysterectomy for cervical cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1806395
– volume: 33
  start-page: 649
  year: 2023
  ident: 10.1136/ijgc-2024-005704_bb0130
  article-title: ESGO/ESTRO/ESP guidelines for the management of patients with cervical cancer - Update 2023
  publication-title: Int J Gynecol Cancer
  doi: 10.1136/ijgc-2023-004429
SSID ssj0009209
Score 2.4029236
Snippet In March 2024, 12 European Network of Young Gynae Oncologists-International Journal of Gynaecological Cancer (ENYGO-IJGC) Editorial Fellows conducted 10...
In March 2024, 12 European Network of Young Gynae Oncologists- (ENYGO-IJGC) Editorial Fellows conducted 10 interviews with senior opinion leaders on original...
SourceID proquest
pubmed
crossref
elsevier
bmj
SourceType Aggregation Database
Index Database
Publisher
StartPage 1522
SubjectTerms Accreditation
Biopsy
Cancer therapies
Cervical Cancer
Collaboration
Congresses as Topic
Developing countries
Disease
Endometrial cancer
Europe
Female
Genital cancers
Genital Neoplasms, Female
Genital Neoplasms, Female - therapy
Gynecologic Surgical Procedures
Gynecological cancer
Gynecology
Humans
Interviews as Topic
LDCs
Lymphatic system
Medical Oncology - methods
Meeting summary
Oncology
Ovarian Cancer
Radiation
Radiation therapy
Spain
Surgery
Tomography
Uterus
Title Highlights from the 25th European Congress on Gynaecological Oncology in Barcelona: the ENYGO-IJGC Fellow Interviews
URI https://ijgc.bmj.com/content/34/10/1522.full
https://dx.doi.org/10.1136/ijgc-2024-005704
https://www.ncbi.nlm.nih.gov/pubmed/39181697
https://www.proquest.com/docview/3101273701
https://www.proquest.com/docview/3151557014
https://www.proquest.com/docview/3097150148
Volume 34
WOSCitedRecordID wos001298326000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1525-1438
  dateEnd: 20241231
  omitProxy: false
  ssIdentifier: ssj0009209
  issn: 1048-891X
  databaseCode: 7X7
  dateStart: 20180101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1525-1438
  dateEnd: 20241231
  omitProxy: false
  ssIdentifier: ssj0009209
  issn: 1048-891X
  databaseCode: BENPR
  dateStart: 20180101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RFiEuvB9bSmUkOHCwmrWT2OZS0dXuAoJthQAtp8iOHdiqOG03peq_x-Mk7Wn3wsWKFMdy9Nkz38zYMwCv3dBpLo2grFIZTQ3PqVahqVRimAn8tIx5un98FrOZnM_VUedwW3bHKnuZGAW1rUv0ke9x1LyZCIx-__SMYtUojK52JTQ2YAvLZmPufDEXN0l32yMeweKQVKrhvA9T8nxvcfyrDCuEpRSvY2KZtg3z53iVclpFPqMSmtz_3-k_gHsd_STv2_XyEG45_wjufOkC7I-hwXMfJ2iwLwnePCGBHxKWNb9J77Yno9pHG53UnkyvvHZlLz_JoY_PV2ThyQFeojwJPP9dHGM8-zk9pB8_TUdkgvGeSxJ9kTEV6hP4Phl_G32gXWEGarjKG6oNlyVPbMmE5la4TNpES1ZxxTWW_EsqoVxmpUxTazODOfWZM9IaYawwQcY-hU1fe_cciGLMMGaHdqh5qqtEujBonmubGpQt-QDeBFyKbmMti2iz8LxA_ArEr2jxG8DbHrnitM3TsaYv76EtOp7R8ociqJE1X-30yN5Mh2N6NMEDrite96gP4NX167CBMSqjvasvQh_M4oXRXTmAZ-3iuv4DrgIBy5XYXj_4C7gbl3I8Y7gDm835hXsJt8u_zWJ5vhv3RGzlLmwdjGdHX_8BrLoR_Q
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9MwHLfGQMCF96MwwEjswMFaYiexjYQQlLUr6zoOA5VTsGMHOo1krBlTvxSfEf-deDu1tx24RJHsWHHy8__9QOiVja1iQnNCS5mSRLOMKOkupYw01U4-LXyd7q9jPpmI6VR-XkN_Qy4MhFUGmugJtakLsJFvMeC8KXcS_bvj3wS6RoF3NbTQaGGxaxdnTmWbvx19dP93k9LB9kF_h3RdBYhmMmuI0kwULDIF5YoZblNhIiVoySRT0K8uKrm0qREiSYxJNRSEp1YLo7k2XMfQJcKR_KuOjnMIIeNTflHktw0pcRqOIELG0-AWZdnW7PBH4RBJEwLpn9AW7or-dbiMGS4Tdj3TG9z-3z7XHXSrE6_x-_Y83EVrtrqHru91AQT3UQNxLUdgkJhjyKzBTv7FNG1-4uCWwP268jYIXFd4uKiULQJ_wPuVv1_gWYU_QJLokdNj3vg1tiffhvtk9GnYxwPwZ51hb2v1pV4foC-XsueHaL2qK_sYYUmpptTEJlYsUWUkrFs0y5RJNNDOrIc2HQ7yjnDMc6-TsSwHvOSAl7zFSw-9DkjJj9s6JCvmsgClvJOjWvkod2xyxVMbAUkXr8Og_BtnDkdLhgPKeujl-bAjUOB1UpWtT90cqFIG3mvRQ49aMJ_vgEknYGaSP1m9-At0Y-dgb5yPR5Pdp-imP0Y-nnIDrTcnp_YZulb8aWbzk-f-PGL0_bIR_Q8fOmzg
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9MwHLfGQBMX3o_CACOxAweriZ3ENhJC0K2lbHQ7wFROwY4d6DSSsWZM_Wp8Ovx34u3U3nbgEkWyY8XJz__3A6FXNraKCc0JLWVKEs0yoqS7lDLSVDv5tPB1ug_3-GQiplN5sIb-hlwYCKsMNNETalMXYCPvM-C8KXcSfb_swiIOtofvTn4T6CAFntbQTqOFyK5dnDv1bf52vO3-9Ralw50vg4-k6zBANJNZQ5RmomCRKShXzHCbChMpQUsmmYLedVHJpU2NEEliTKqhODy1WhjNteE6ho4Rjvxf54xxaBvBp_yy4G8bXuK0HUGEjKfBRcqy_uzoR-HQSRMCqaDQIu6a_nW0jDEuE3w9Axze_p8_3R10qxO78fv2nNxFa7a6hzY-d4EF91ED8S7HYKiYY8i4wU4uxjRtfuLgrsCDuvK2CVxXeLSolC0C38D7lb9f4FmFP0Dy6LHTb974NXYm30b7ZPxpNMBD8HOdY2-D9SVgH6CvV7Lnh2i9qiv7GGFJqabUxCZWLFFlJKxbNMuUSTTQ1KyHthwm8o6gzHOvq7EsB-zkgJ28xU4PvQ6oyU_a-iQr5rIAq7yTr1q5KXfsc8VTmwFVl6_DoCwcd6iPlwwHxPXQy4thR7jAG6UqW5-5OVC9DLzaoocetcC-2AGTTvDMJH-yevEXaMMBOd8bT3afopv-RPkwy0203pye2WfoRvGnmc1Pn_ujidH3qwb0PxRMdZQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Highlights+from+the+25th+European+Congress+on+Gynaecological+Oncology+in+Barcelona%3A+the+ENYGO-IJGC+Fellow+Interviews&rft.jtitle=International+journal+of+gynecological+cancer&rft.au=Martina+Aida+Angeles&rft.au=Agusti%2C+Nuria&rft.au=Bonaldo%2C+Giulio&rft.au=Bizzarri%2C+Nicol%C3%B2&rft.date=2024-10-01&rft.pub=Elsevier+Limited&rft.issn=1048-891X&rft.eissn=1525-1438&rft.volume=34&rft.issue=10&rft.spage=1522&rft.epage=1528&rft_id=info:doi/10.1136%2Fijgc-2024-005704&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1048-891X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1048-891X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1048-891X&client=summon